Fingerprint
Dive into the research topics of 'Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies
Shivaani Kummar*, Martin Gutierrez, Erin R. Gardner, Erin Donovan, Kyunghwa Hwang, Joo Chung Eun, Min Jung Lee, Kim Maynard, Mikhail Kalnitskiy, Alice Chen, Giovanni Melillo, Qin C. Ryan, Barbara Conley, William D. Figg, Jane B. Trepel, James Zwiebel, James H. Doroshow, Anthony J. Murgo
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
118
Scopus
citations